Loading...
XSTOZICC
Market cap2mUSD
Dec 23, Last price  
0.47SEK
1D
21.93%
1Q
-86.66%
IPO
-98.42%
Name

Ziccum AB

Chart & Performance

D1W1MN
XSTO:ZICC chart
P/E
P/S
6.36
EPS
Div Yield, %
0.00%
Shrs. gr., 5y
30.97%
Rev. gr., 5y
75.20%
Revenues
4m
+21,941.18%
0227,000654,0005,0005,00017,0003,747,000
Net income
-21m
L-24.75%
-518,667-4,571,000-8,725,000-17,343,000-21,156,000-28,454,000-21,412,000
CFO
-20m
L+48.02%
-160,000-3,830,000-8,325,000-17,039,000-16,102,000-13,391,000-19,821,000
Earnings
Jan 29, 2025

Profile

Ziccum AB (publ) develops dry powder preparations of biological pharmaceuticals. It develops and commercializes LaminarPace, a spray drying technology that dries chemicals, vaccines, biologics, and drug substances at room temperature. The company was founded in 2017 and is headquartered in Lund, Sweden.
IPO date
Oct 25, 2018
Employees
8
Domiciled in
SE
Incorporated in
SE

Valuation

Title
SEK in thousands, except ratios and share amounts
FYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑12
Income
Revenues
3,747
21,941.18%
17
240.00%
5
0.00%
Cost of revenue
27,033
1,373
22,464
Unusual Expense (Income)
NOPBT
(23,286)
(1,356)
(22,459)
NOPBT Margin
Operating Taxes
(334)
20
Tax Rate
NOPAT
(23,286)
(1,022)
(22,479)
Net income
(21,412)
-24.75%
(28,454)
34.50%
(21,156)
21.99%
Dividends
Dividend yield
Proceeds from repurchase of equity
27,967
2,413
BB yield
Debt
Debt current
571
571
571
Long-term debt
286
857
1,429
Deferred revenue
Other long-term liabilities
(857)
(1,429)
Net debt
(2,137)
(21,523)
(10,273)
Cash flow
Cash from operating activities
(19,821)
(13,391)
(16,102)
CAPEX
(136)
(3,898)
(6,424)
Cash from investing activities
(136)
(3,898)
(6,424)
Cash from financing activities
27,967
1,179
FCF
(22,460)
510
(28,269)
Balance
Cash
2,994
22,951
12,273
Long term investments
Excess cash
2,807
22,950
12,273
Stockholders' equity
(96,816)
(76,099)
(48,169)
Invested Capital
106,257
106,139
79,448
ROIC
ROCE
EV
Common stock shares outstanding
13,873
13,865
11,053
Price
Market cap
EV
EBITDA
(22,068)
4,053
(21,617)
EV/EBITDA
Interest
167
20
Interest/NOPBT